Summary
Teradyne, Inc. (TER) filed an 8-K on September 27, 2011, to report a significant regulatory milestone in its previously announced merger agreement with LitePoint Corporation. The filing indicates that the Federal Trade Commission (FTC) granted early termination of the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 on September 26, 2011. This early termination signifies that regulatory antitrust review by the FTC has been completed and no further objections were raised regarding the proposed acquisition. This is a crucial step that removes a major hurdle for the transaction and signals progress towards the closing of the merger. Investors should view this as a positive development, as it reduces the uncertainty surrounding the completion of the LitePoint acquisition.
Key Highlights
- 1Teradyne announced the early termination of the Hart-Scott-Rodino (HSR) waiting period by the Federal Trade Commission (FTC) on September 26, 2011.
- 2This early termination relates to the previously announced merger agreement between Teradyne and LitePoint Corporation.
- 3The HSR Act clearance is a key regulatory approval required for the completion of the merger.
- 4The FTC's decision indicates that the proposed acquisition of LitePoint does not raise antitrust concerns.
- 5This development removes a significant regulatory obstacle for the merger.
- 6The early termination of the HSR waiting period is a positive step towards the closing of the LitePoint acquisition.